1、Stock code:603883 stock abbreviation:LBXLBX Pharmacy Chain Co., Ltd.Institutional investor conference call1、Proceedings(1)Conference date:15 December 2022(2)Conference format:Online (3)Conference venue:Company meeting room(4)Participants: 1.Company participants: Board Secretary: Shini FengSecurities
2、 Representative: Xiaer LiuInvestor Relations: Linyi He2.Conference call participants: Morgan Stanley, Blackstone Group, UBS Asset Management, Apah Capital, Destination Partners, Ellerston Capital, Eurizon Capital, Franklin Templeton Investments, Helved Capital Management Limited, Janus Henderson Inv
3、estors, Jetha Global, Manulife Investment Management, Matthews International Capital Management, Millennium Partners, Oberweis Asset Management, Orbimed Advisors, Pictet Asset Management, Quest Management, Snow Lake Capital, Stillpoint Investments, Torq Capital Management, Tree Line Advisors, Trikon
4、 Asset Management, TT International, UBS, Ug Investment Advisors, Orbimed Advisors and etc.(34 participants from international investment institution in total)2、Main content (1)Brief introduction by Shini FengThe effectiveness of the companys digital reform and efficient organizational reform has gr
5、adually emerged since the third quarter of last year, and our business performance has continued to improve. In the first three quarters of this year, the company realized total revenue of RMB13.78 billion, an increase of 22.13% over the same period last year; Net profit attributable to shareholders
6、 of RMB610 million has been achieved, showing an increase of 14.46% year on year; Net profit attributable to shareholders of the company before non-recurring gains and losses of RMB567 million reached 18.88% growth over the same period. For the third quarter, the company realized total revenue of RM